Merck KGaA

Bavencio fails second ovarian cancer Phase III trial
Bavencio fails second ovarian cancer Phase III trial
BioCentury
Merck KGaA
Bavencio
ovarian cancer
Flag link:
Merck KGaA hands off its CAR-T R&D operations to Intrexon in $175M deal
Merck KGaA hands off its CAR-T R&D operations to Intrexon in $175M deal
Endpoints
Merck KGaA
CAR-T
Intrexion
M&A
Flag link:
Merck's Keytruda puts heat on Pfizer, Merck KGaA's Bavencio with new Merkel cell OK
Merck's Keytruda puts heat on Pfizer, Merck KGaA's Bavencio with new Merkel cell OK
Fierce Pharma
Merck
Keytruda
Pfizer
Merck KGaA
Bavencio
Merkel cell carcinoma
Flag link:
Merck KGaA links with AI firm to iron out side-effects during R&D
Merck KGaA links with AI firm to iron out side-effects during R&D
Pharmaforum
Merck KGaA
R&D
artificial intelligence
Cyclica
drug development
Flag link:
Merck KGaA Partners With Startup for Image Tagging Software
Merck KGaA Partners With Startup for Image Tagging Software
Yahoo/Bloomberg
Merck KGaA
V7
artificial intelligence
Flag link:
Syntropy, a Merck KGaA – Palantir JV aiming to apply big data to cancer research
Syntropy, a Merck KGaA – Palantir JV aiming to apply big data to cancer research
GoinPharma
Merck KGaA
Palantir Technologies
Syntropy
cancer
Big Data
Flag link:
A Small Group of Pharma Companies Is Making the Bulk of Medicines Necessary for Developing Countries
A Small Group of Pharma Companies Is Making the Bulk of Medicines Necessary for Developing Countries
BioSpace
GSK
JNJ
Novartis
Merck KGaA
Sanofi
Takeda
developing countries
Flag link:
Merck KGaA Enters Field of Big Data With Joint Venture With Palantir Technologies
Merck KGaA Enters Field of Big Data With Joint Venture With Palantir Technologies
BioSpace
Big Data
Merck KGaA
Palantir Technologies
Syntropy
cancer
Flag link:
Merck KGaA and Pfizer say drug failed to meet primary endpoints in late-stage ovarian cancer trial
Merck KGaA and Pfizer say drug failed to meet primary endpoints in late-stage ovarian cancer trial
Marketwatch
Merck KGaA
Pfizer
avelumab
ovarian cancer
clinical trials
Flag link:
Immunicum Announces Collaboration with Merck KGaA and Pfizer to Evaluate Cell Therapy Treatment in Combination with Avelumab
Immunicum Announces Collaboration with Merck KGaA and Pfizer to Evaluate Cell Therapy Treatment in Combination with Avelumab
CP Wire
Immunicum
immuno-oncology
Merck KGaA
Pfizer
avelumab
Flag link:
Merck KGaA’s bold new approach to cancer immunotherapy
Merck KGaA’s bold new approach to cancer immunotherapy
Pharmaforum
Merck KGaA
cancer immunotherapy
M7824
Flag link:
Merck KGaA says might strike partnership deal this year
Merck KGaA says might strike partnership deal this year
Yahoo/Reuters
Merck KGaA
R&D
Flag link:
Merck KGaA posts mixed data from their big PhIIb MS study on evobrutinib — spurring plenty of questions
Merck KGaA posts mixed data from their big PhIIb MS study on evobrutinib — spurring plenty of questions
Endpoints
Merck KGaA
evobrutinib
MS
multiple sclerosis
Flag link:
Merck KGaA, Pfizer's immuno-drug shown to alleviate kidney cancer
Merck KGaA, Pfizer's immuno-drug shown to alleviate kidney cancer
Yahoo/Reuters
Merck KGaA
Bavencio
Pfizer
kidney cancer
Inlyta
Flag link:
Merck's Keytruda threatens Pfizer, Merck KGaA's Bavencio with Merkel cell 'priority' tag
Merck's Keytruda threatens Pfizer, Merck KGaA's Bavencio with Merkel cell 'priority' tag
Fierce Pharma
Merck
Keytruda
Pfizer
Merck KGaA
Bavencio
Merkel cell carcinoma
FDA
Flag link:
Analyst sees positive future for Merck KGaA in MS market, as FDA accepts Mavenclad for review
Analyst sees positive future for Merck KGaA in MS market, as FDA accepts Mavenclad for review
The Pharma Letter
Merck KGaA
Mavenclad
cladribine
MS
multiple sclerosis
Flag link:
Leap Therapeutics To Collaborate With Merck, Pfizer To Evaluate TRX518
Leap Therapeutics To Collaborate With Merck, Pfizer To Evaluate TRX518
Business Insider
Leap Therapeutics
Pfizer
Merck KGaA
TRX518
avelumab
solid tumors
Flag link:
J&J taps German Merck to market Invokana in China
J&J taps German Merck to market Invokana in China
Biopharma Dive
JNJ
Xian-Janssen
Merck KGaA
Invokana
China
Flag link:
P&G: healthcare acquisition helps us stay on top of consumer 'megatrends'
P&G: healthcare acquisition helps us stay on top of consumer 'megatrends'
Medical Marketing and Media
Procter & Gamble
consumer health
Merck KGaA
Flag link:
Procter & Gamble Acquires Consumer Health Unit of Merck KGaA for $4.2B
Procter & Gamble Acquires Consumer Health Unit of Merck KGaA for $4.2B
CP Wire
Procter & Gamble
Merck KGaA
M&A
consumer health
Flag link:

Pages